KeithSuárez Jaramillo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
KeithSuárez Jaramillo has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- EdgarI Preciado Mesa
Department of Neurosurgery, University of Cartagena, Hospital Universitario del Caribe, Cartagena de Indias, Colombia
1 shared publication - Gabriel Alcalá-Cerra
Department of Neurosurgery, University of Cartagena, Hospital Universitario del Caribe, Cartagena de Indias, Colombia
1 shared publication - JuanJ Gutiérrez Paternina
Department of Medicine, University of Cartagena, Hospital Universitario del Caribe, Cartagena de Indias, Colombia
1 shared publication - Lucíam Niño-Hernández
Department of Pathology, Universidad de Cartagena - Hospital Universitario del Caribe. Barrio Zaragocilla, Hospital Universitario del Caribe. Cartagena de Indias, Colombia
1 shared publication - Maríae Buendía de Ávila
Department of Medicine, University of Cartagena, Hospital Universitario del Caribe, Cartagena de Indias, Colombia
1 shared publication - Rubénsabogal Barrios
Department of Neurosurgery, University of Cartagena, Hospital Universitario del Caribe, Cartagena de Indias, Colombia
1 shared publication
Latest Publications
- Open Access
- 1 January 2011
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 2 (1) , 125
Treatment of aneurysmal subarachnoid hemorrhage and unruptured intracranial aneurysms by neurosurgeons in Colombia: A survey
Trends in management of aneurysmal subarachnoid hemorrhage and unruptured intracranial aneurysms among neurosurgeons is very variable and had not been previously described in any Latin American country. This study was conducted to determine the preferences of Colombian neurosurgeons in pharmacologic, surgical, and endovascular management of patients with aneurysmal subarachnoid hemorrhage and unruptured intracranial aneurysms. A survey-based descriptive study was performed in a sample of members from the Colombian Association of Neurosurgery. Questions about pharmacologic, surgical, and endovascular management of aneurysmal subarachnoid hemorrhage and unruptured intracranial aneurysm were carried out. We calculated the mean and the standard deviation of the results obtained from the continuous variables. The results of the categorical variables are presented as percentages. The preference of medication with poor clinical evidence, such as magnesium sulfate, aspirin, statins, and anti-fibrinolytics was lower than 10%. The use of intravenous nimodipine and systemic glucocorticoids was as high as 31%. The availability of endovascular therapy was 69%. The indication for treatment of patients with unruptured intracranial aneurysms that required intervention was less than 13.8%. In patients with ruptured or unruptured intracranial aneurysms, coiling was the preferred method for exclusion. Reported compliance of evidence-based clinical guidelines was similar to that described in developed countries, and even better. However, there is little agreement in treating patients with unruptured intracranial aneurysms. For other issues, the conducts reported by Colombian neurosurgeons are in accordance with the current guidelines.
- 1 January 2011
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 2 (1) , 125
Open AccessTreatment of aneurysmal subarachnoid hemorrhage and unruptured intracranial aneurysms by neurosurgeons in Colombia: A survey
Trends in management of aneurysmal subarachnoid hemorrhage and unruptured intracranial aneurysms among neurosurgeons is very variable and had not been previously described in any Latin American country. This study was conducted to determine the preferences of Colombian neurosurgeons in pharmacologic, surgical, and endovascular management of patients with aneurysmal subarachnoid hemorrhage and unruptured intracranial aneurysms. A survey-based descriptive study was performed in a sample of members from the Colombian Association of Neurosurgery. Questions about pharmacologic, surgical, and endovascular management of aneurysmal subarachnoid hemorrhage and unruptured intracranial aneurysm were carried out. We calculated the mean and the standard deviation of the results obtained from the continuous variables. The results of the categorical variables are presented as percentages. The preference of medication with poor clinical evidence, such as magnesium sulfate, aspirin, statins, and anti-fibrinolytics was lower than 10%. The use of intravenous nimodipine and systemic glucocorticoids was as high as 31%. The availability of endovascular therapy was 69%. The indication for treatment of patients with unruptured intracranial aneurysms that required intervention was less than 13.8%. In patients with ruptured or unruptured intracranial aneurysms, coiling was the preferred method for exclusion. Reported compliance of evidence-based clinical guidelines was similar to that described in developed countries, and even better. However, there is little agreement in treating patients with unruptured intracranial aneurysms. For other issues, the conducts reported by Colombian neurosurgeons are in accordance with the current guidelines.